Terms: = Liver cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468
78 results:
1. Effects of silymarin supplementation on liver and kidney functions: A systematic review and dose-response meta-analysis.
Mohammadi S; Ashtary-Larky D; Asbaghi O; Farrokhi V; Jadidi Y; Mofidi F; Mohammadian M; Afrisham R
Phytother Res; 2024 May; 38(5):2572-2593. PubMed ID: 38475999
[TBL] [Abstract] [Full Text] [Related]
2. Effect of bevacizumab administered prior to transarterial chemoembolization on the therapeutic effects of lenvatinib given post-TACE in primary liver cancer patients.
Dang Z; Jiang L; Huang F
Int J Clin Pharmacol Ther; 2023 Oct; 61(10):423-429. PubMed ID: 37548453
[TBL] [Abstract] [Full Text] [Related]
3. Elevated stil predicts poor prognosis in patients with hepatocellular carcinoma.
Song H; Zhao H; Chen C; Zhang D; Wang X; He J
Medicine (Baltimore); 2023 Feb; 102(7):e33004. PubMed ID: 36800576
[TBL] [Abstract] [Full Text] [Related]
4. Quaternized Acridine Maleimide MALDI Probe Enables Mass Spectrometry Imaging of Thiols.
Ma Z; Yuan J; Xu J; Li L; Tang C; Chang L; Quinn RJ; Qin L; Liu J; Ye Y
Anal Chem; 2022 Nov; 94(43):14917-14924. PubMed ID: 36269144
[TBL] [Abstract] [Full Text] [Related]
5. "A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring".
Soledad Poetto A; Posocco B; Zanchetta M; Gagno S; Orleni M; Canil G; Alberti M; Puglisi F; Toffoli G
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Sep; 1207():123403. PubMed ID: 35940043
[TBL] [Abstract] [Full Text] [Related]
6. Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis.
Yi G; Huang Z; Huang Z; Wang Y; Deng W; Zheng S; Li T
Front Immunol; 2022; 13():914265. PubMed ID: 35874753
[TBL] [Abstract] [Full Text] [Related]
7. sil-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
Barak V; Kalickman I; Pe'er J
Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
[TBL] [Abstract] [Full Text] [Related]
8. Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma.
Makkouk A; Yang XC; Barca T; Lucas A; Turkoz M; Wong JTS; Nishimoto KP; Brodey MM; Tabrizizad M; Gundurao SRY; Bai L; Bhat A; An Z; Abbot S; Satpayev D; Aftab BT; Herrman M
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34916256
[TBL] [Abstract] [Full Text] [Related]
9. The Value of Contrast-Enhanced Ultrasound liver Imaging Reporting and Data System in the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
Peng J; Zhang T; Wang H; Ma X
J Ultrasound Med; 2022 Jun; 41(6):1537-1547. PubMed ID: 34617296
[TBL] [Abstract] [Full Text] [Related]
10. Circular RNA Circ-stil Contributes to Cell Growth and Metastasis in Hepatocellular Carcinoma via Regulating miR-345-5p/AQP3 Axis.
Liu J; He X; Zou Y; Wang K
Dig Dis Sci; 2022 Jun; 67(6):2269-2282. PubMed ID: 34231101
[TBL] [Abstract] [Full Text] [Related]
11. Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization.
Ma XL; Qu XD; Yang WJ; Wang BL; Shen MN; Zhou Y; Zhang CY; Sun YF; Chen JW; Hu B; Gong ZJ; Zhang X; Pan BS; Zhou J; Fan J; Yang XR; Guo W
Clin Chim Acta; 2020 Dec; 511():67-74. PubMed ID: 32979338
[TBL] [Abstract] [Full Text] [Related]
12. Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis.
XiaoHong C; Bo S; FangFang X; Man G; JianZhou Z; ZhongHua L; WenLv L; XueSen C; XiaoQiang D; Boheng Z
Int J Clin Oncol; 2019 Sep; 24(9):1151-1160. PubMed ID: 31183777
[TBL] [Abstract] [Full Text] [Related]
13. silibinin A decreases statin‑induced PCSK9 expression in human hepatoblastoma HepG2 cells.
Dong Z; Zhang W; Chen S; Liu C
Mol Med Rep; 2019 Aug; 20(2):1383-1392. PubMed ID: 31173243
[TBL] [Abstract] [Full Text] [Related]
14. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
[TBL] [Abstract] [Full Text] [Related]
15. Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early-intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial.
Lee TY; Lin CC; Chen CY; Wang TE; Lo GH; Chang CS; Chao Y
Medicine (Baltimore); 2017 Sep; 96(37):e7655. PubMed ID: 28906355
[TBL] [Abstract] [Full Text] [Related]
16. Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas.
Wong ET; Timmons J; Callahan A; O'Loughlin L; Giarusso B; Alsop DC
BMC Cancer; 2016 Nov; 16(1):914. PubMed ID: 27876012
[TBL] [Abstract] [Full Text] [Related]
17. IL-15/sil-15Rα gene transfer suppresses Lewis lung cancer growth in the lungs, liver and kidneys.
Sun H; Liu D
Cancer Gene Ther; 2016; 23(2-3):54-60. PubMed ID: 26742578
[TBL] [Abstract] [Full Text] [Related]
18. Higher proliferation of peritumoral endothelial cells to IL-6/sil-6R than tumoral endothelial cells in hepatocellular carcinoma.
Zhuang PY; Wang JD; Tang ZH; Zhou XP; Quan ZW; Liu YB; Shen J
BMC Cancer; 2015 Nov; 15():830. PubMed ID: 26525581
[TBL] [Abstract] [Full Text] [Related]
19. Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma.
Masuda A; Arai K; Nishihara D; Mizuno T; Yuki H; Kambara T; Betsunoh H; Abe H; Yashi M; Fukabori Y; Yoshida K; Kamai T
Biomed Res Int; 2014; 2014():396064. PubMed ID: 25089268
[TBL] [Abstract] [Full Text] [Related]
20. Clinical significance of joint detection of serum VEGF, sil-2R and HGF in patients with primary hepatocellular carcinoma before and after percutaneous microwave coagulation therapy.
Chen JD; Xiong YQ; Dong K; Luo J; Yue LX; Chen Q
Asian Pac J Cancer Prev; 2014; 15(11):4545-8. PubMed ID: 24969882
[TBL] [Abstract] [Full Text] [Related]
[Next]
